Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies, and governments.
Sign up today and learn more about Tilray Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Tilray Stock
Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies and governments. Tilray cultivates and delivers the benefits of medical cannabis safely and reliably. Healthcare practitioners and patients expect and deserve only the best service and products. Accordingly, Tilray provides expedited delivery, prompt follow-up, and consistent quality of each strain they harvest.
Seeking Alpha - Jun, 27 2018Tilray Seeks $100 Million IPO In US Filing
International Financing Review - Jun, 25 2018Canada: Tilray files for US float
PitchBook News & Analysis - Jun, 22 2018Canadian cannabis company cultivates IPO
Axios - Jun, 21 2018Tilray files for IPO, after Canada legalizes marijuana
Business Wire (press release) - Apr, 4 2018Tilray® Launches High Park Company™ to Produce and Distribute Adult-Use Cannabis in Canada
Business Wire (press release) - Mar, 19 2018Tilray® Forms Strategic Alliance with Leading Pharmaceutical Company in Canada
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase